Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
58
SYM Quote, Financials, Valuation and Earnings
Last price:
$69.90
Seasonality move
:
21.23%
Day range:
$65.84 - $69.31
52-week range:
$16.32 - $87.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.29x
P/B ratio:
34.91x
Volume:
1.2M
Avg. volume:
2.9M
1-year change:
170.63%
Market cap:
$7.7B
Revenue:
$2.2B
EPS (TTM):
-$0.16
Earnings Data
Next earnings date for SYM
Feb 04
2026
Most recent earnings per share
-$0.03
Missed by $0.11
(Nov 24/2025)
Consensus Estimate
$0.08
(Nov 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SYM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $639.2M | -- | -- | $0.10 | -- |
| 02/04/2026 | Q4 | $622.6M | -- | -- | $0.09 | -- |
| 11/24/2025 | Q3 | $604M | $618.5M | -$0.03 | $0.08 | -$0.11 |
| 08/06/2025 | Q2 | $533.2M | $592.1M | -$0.05 | $0.05 | -$0.10 |
| 05/07/2025 | Q1 | $522.4M | $549.7M | -$0.04 | $0.05 | -$0.09 |
| 02/05/2025 | Q4 | $490M | $486.7M | -$0.03 | $0.03 | -$0.06 |
| 11/18/2024 | Q3 | $470.3M | $576.8M | $0.05 | $0.06 | -$0.02 |
| 07/29/2024 | Q2 | $463.8M | $470.3M | -$0.05 | $0.06 | -$0.10 |
| 05/06/2024 | Q1 | $412.9M | $393.3M | -$0.09 | $0.02 | -$0.11 |
| 02/05/2024 | Q4 | $368.2M | $359.9M | -$0.03 | $0.02 | -$0.06 |
| 11/20/2023 | Q3 | -- | $391.9M | -$0.06 | -- | -- |
| 07/31/2023 | Q2 | -- | $311.8M | -$0.04 | -- | -- |
| 05/01/2023 | Q1 | -- | $266.9M | -$0.06 | -- | -- |
| 01/30/2023 | Q4 | -- | $206.3M | -$0.07 | -- | -- |
| 11/21/2022 | Q3 | -- | $244.4M | -$0.05 | -- | -- |
| 08/01/2022 | Q2 | -- | $175.6M | -$0.01 | -- | -- |
| 03/31/2022 | Q1 | -- | $96.3M | -$0.30 | -- | -- |
| 12/31/2021 | Q4 | -- | $77.1M | -$0.23 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.02 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.06 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.01 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.00 | -- | -- |
Symbotic, Inc. Earnings Questions
-
How Much did Symbotic, Inc. Generate in Revenue Last Quarter?
Symbotic, Inc. reported $618.5M worth of top line sales in its most recent quarter.
-
Did Symbotic, Inc. Beat Earnings Last Quarter?
Symbotic, Inc. announced earnings per share of -$0.03 which represents a miss of analyst forecast a $0.08 per share.
-
Is Symbotic, Inc. Profitable?
Symbotic, Inc. reported $119.5M that represents $1.07 per share over the last quarter.
-
What is the Analyst Consensus for Symbotic, Inc. EPS Next Year?
Symbotic, Inc.'s earnings are forecast to decrease from -$0.16 per share to $0.26 per share next year representing a decrease of -54.34%.
-
When is Symbotic, Inc.'s Earnings Date?
Symbotic, Inc.'s next earnings date is February 4, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 20.06% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.9% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 2.67% over the past day.
